Accordingly, by secreting CXCL12 and IGF-1, mesenchymal stromal cells from triple negative breast tumors have recently been shown to positively select cancer clones with high Src activity and propensity for bone metastasis (Zhang et al., 2013). The gene discussed is CXCL12; the disease is cancer.